Bioterrorism threats and infectious disease outbreaks are on the rise. Emergent BioSolutions Inc. (EBS) has a stream of revenues from FDA-approved drugs, as well as a full pipeline of drugs under development, to combat these health threats.
QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today launched enhancements in its QIAGEN Clinical Insight (QCI) bioinformatics software automating the AMP/ASCO/CAP Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer, advancing precision medicine with the first solution to offer molecular pathologists critical information needed to guide oncologists’ treatment decisions.
FDA approval based on Phase III program demonstrating up to 51% reduction in asthma exacerbations, significant improvement in lung function and a 75% reduction in daily oral steroid use
Date and time: Tuesday, 21 November 5:00PM – 8:00PM EST
Location: MedImmune 1 Medimmune Way Gaithersburg, MD 20878 United States
HBA Mid-Atlantic presents a panel of successful diverse women from the public and private healthcare sectors to share their experiences on harnessing one’s power.
- Primary Competency: 8. Builds relationships and teams
- Secondary Competency: 12. Continues to learn, grow and transform
Scientists for the first time have tried editing a gene inside the body in a bold attempt to permanently change a person’s DNA to cure a disease.
David Narrow said the life of an entrepreneur is fast-paced and at times very stressful, but he has never loved any job more.
His medical technology firm, Sonavex, recently raised $3 million and took up new office space in Canton. The company is currently working on commercializing its product, which uses ultrasound technology to detect potentially harmful, post-surgical blood clots.
Date: Thursday, November 30, 2017
Location: Inova Center for Personalized Health3225 Gallows Road, Fairfax, VA 22031
Technology innovation continues to accelerate at an exponential rate, constantly outpacing the status quo and redefining limitations. Personal healthcare stands to benefit from these newfound opportunities.
Happiness changes over the course of your life.
There is “scientific evidence that people get happier as they get older,” according to a Bank of America Merrill Lynch report that analyzed Nielsen data. “While there are differing theories as to why this is, most agree that it is an acceptance of aging that promotes contentedness.”
It just wouldn’t feel like a Friday without some Trump cabinet intrigue so with that in mind, Alex Azar, the former president of Lilly’s U.S. business, has been tipped to be the next Secretary of Health and Human Services, according to Bloomberg. If he’s approved, Azar would succeed Tom Price, who resigned from the post amidst fallout over the cost of his extensive use of government travel via military and private jets.
AstraZeneca and its Maryland-based biologics research and development arm, MedImmune, announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted a positive opinion, recommending benralizumab as an add-on maintenance treatment in adult patients with a type of severe asthma.